Evidence map›Paper›PMID 33934523›Full record

ArticleCancer medicine2021

Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer.

Zhongbo Zhang, Yuanhong Xu, Chenghai Zhao

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. FZD7 expression marks mammary tumor-initiating cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Roles of Secreted Wnt Ligands in Cancer.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zhongbo ZhangDepartment of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang, P.R. China.ORCID 0000-0003-1935-5912
Yuanhong XuDepartment of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang, P.R. China.
Chenghai ZhaoDepartment of Pathophysiology, Basic Medical College, China Medical University, Shenyang, P.R. China.
First Hospital of China Medical University · CNShenyang Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mining databases and data obtained from assays on human specimens had shown that Fzd7 is closely associated with Wnt7b, that Fzd7/Wnt7b expression is upregulated in pancreatic cancer tissues compared with normal tissues, and its expression is negatively correlated with survival. Fzd7/Wnt7b knockdown in Capan-2 and Panc-1 cells reduced the proliferative capacity of pancreatic cancer stem cells (PCSCs), reduced drug resistance, decreased the percentage of CD24

Indexed as

ATP Binding Cassette Transporter, Subfamily G, Member 2beta CateninCD24 AntigenCell Line, TumorCell ProliferationDeoxycytidineDrug Resistance, NeoplasmFemaleFrizzled ReceptorsGemcitabineGene Expression Regulation, NeoplasticHumansHyaluronan ReceptorsMaleMiddle AgedNeoplastic Stem CellsATP Binding Cassette Transporter, Subfamily G, Member 2beta CateninCD24 AntigenDeoxycytidineFrizzled ReceptorsFZD7 protein, humanGemcitabineHyaluronan ReceptorsWNT7B protein, humanWnt ProteinschemoresistanceFzd7/Wnt7bpancreatic cancerstemnessWnt signaling pathway

Identifiers

PMID33934523
PMCPMC8124113
OpenAlexW3159037839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.